Plasma copper and zinc levels in patients with malignant tumors of digestive organs.Clinical evaluation of the Cu/Zn ratio
- 1 August 1978
- Vol. 42 (2) , 626-631
- https://doi.org/10.1002/1097-0142(197808)42:2<626::aid-cncr2820420232>3.0.co;2-f
Abstract
The plasma copper level (PCL) and plasma zinc level (PZL) were determined in 126 patients: 54 had carcinomas of which 40 were carcinomas of the digestive organs, 37 had benign lesions, and 35 were without disease. The PCL increased and the PZL decreased significantly in the group with carcinoma of the digestive organs. The Cu/Zn ratio was not only significantly higher than in the normal group, but also was high in cases with advanced carcinoma especially when liver metastasis was present. Therefore, the Cu/Zn ratio may be valuable in estimating the extent of the carcinoma as well as in determining the prognosis of the cancer patients.This publication has 12 references indexed in Scilit:
- Copper and zinc levels in serum from human patients with sarcomasCancer, 1976
- Serum Zinc Concentration in Acute Myocardial InfarctionChest, 1974
- Serum copper observations in patients with malignant lymphomaCancer, 1973
- Significance of serum copper levels in adult patients with Hodgkin's diseaseCancer, 1973
- Copper and Zinc Concentration in the Plasma of Leukaemic ChildrenBritish Journal of Haematology, 1973
- The general rules for the gastric cancer study in surgerySurgery Today, 1973
- PLASMA-ZINC CONCENTRATION IN PATIENTS WITH BRONCHOGENIC CANCERThe Lancet, 1972
- PLASMA-ZINC AND COPPER IN PREGNANCY AND AFTER ORAL CONTRACEPTIVESThe Lancet, 1968
- Plasma Zinc Concentration in Liver DiseasesGastroenterology, 1968
- Biochemistry, Physiology and Pathology of ZincPhysiological Reviews, 1959